Russell Investments Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-137,993
| Closed | -$12.8M | – | 3024 |
|
|
2021
Q4 | $12.8M | Sell |
137,993
-29,324
| -18% | -$1.93M | 0.02% | 785 |
|
|
2021
Q3 | $9.96M | Buy |
167,317
+88,286
| +112% | +$5.21M | 0.02% | 880 |
|
|
2021
Q2 | $5.39M | Buy |
79,031
+72,315
| +1,077% | +$4.71M | 0.01% | 1298 |
|
|
2021
Q1 | $465K | Buy |
6,716
+4,386
| +188% | +$338K | ﹤0.01% | 2555 |
|
|
2020
Q4 | $179K | Sell |
2,330
-4,386
| -65% | -$329K | ﹤0.01% | 2784 |
|
|
2020
Q3 | $502K | Buy |
6,716
+2,330
| +53% | +$155K | ﹤0.01% | 2393 |
|
|
2020
Q2 | $276K | Sell |
4,386
-20,144
| -82% | -$1.11M | ﹤0.01% | 2603 |
|
|
2020
Q1 | $1.03M | Sell |
24,530
-16,177
| -40% | -$742K | ﹤0.01% | 1828 |
|
|
2019
Q4 | $1.85M | Sell |
40,707
-29,611
| -42% | -$1.4M | ﹤0.01% | 1792 |
|
|
2019
Q3 | $3.22M | Buy |
70,318
+16,256
| +30% | +$914K | 0.01% | 1423 |
|
|
2019
Q2 | $3.16M | Buy |
+54,062
| New | +$2.79M | 0.01% | 1447 |
|
|
2019
Q1 | – | Sell |
-5,244
| Closed | -$204K | – | 3062 |
|
|
2018
Q4 | $204K | Buy |
+5,244
| New | +$206K | ﹤0.01% | 2597 |
|
Russell Investments Group's ARNA Position: Q1 2022 in Review
Russell Investments Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 137,993 shares — an estimated $12.8M sold.
Russell Investments Group first reported a position in ARNA in Q4 2018 and held it in 12 quarters. The position peaked at $12.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Russell Investments Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Russell Investments Group sold 137,993 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $12.8M.
- Russell Investments Group first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 12 quarters.
- Russell Investments Group's Arena Pharmaceuticals Inc position peaked at $12.8M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Russell Investments Group's 13F filing for Q1 2022, filed 5 May 2022.